| Cas No.: | 1340593-59-0 |
| Chemical Name: | Oteseconazole |
| Synonyms: | Oteseconazole;VHH774W97N;BDBM50046187;DB13055;SB17420;2-Pyridineethanol, alpha-(2,4-difluorophenyl)-beta,beta-difluoro-alpha-(1H-tetrazol-1-ylmethyl)-5-(4-(2,2,2-trifluoroethoxy)phenyl)-, (alphaR)-;(2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-{5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl}propan-2-ol;C. albicans;T. rubrum |
| SMILES: | FC(C1C=CC(C2C=CC(=CC=2)OCC(F)(F)F)=CN=1)([C@@](C1C=CC(=CC=1F)F)(CN1C=NN=N1)O)F |
| Formula: | C23H16F7N5O2 |
| M.Wt: | 527.39 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | VT-1161 is a potent, highly-selective, and oral fungal CYP51 inhibitor with Kd of ≤ 39 nM; demonstrates >2,000-fold selectivit over human CYP51, weakly inhibits human CYP2C9, CYP2C19, and CYP3A4; exhibits excellent potency against key yeast and dermatophyte strains.Fungal InfectionPhase 2 Clinical |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
